Monrol to supply Telix with Lu-177 for renal cancer trial
May 11, 2022 -- Eczacıbaşı-Monrol Nuclear Products will provide lutetium-177 (Lu-177) to Telix Pharmaceuticals Limited for a phase II clinical trial of its Starlite 2 renal cancer therapy medication TLX250. Read More
Accuray touts ESTRO 2022 research presentations
May 10, 2022 -- Radiation therapy firm Accuray said that more than 70 abstracts reporting on the use of its CyberKnife and TomoTherapy technologies were presented at the annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Copenhagen this week. Read More
AUA, ASTRO release new prostate cancer guideline
May 10, 2022 -- The American Urological Association (AUA) and the American Society for Radiation Oncology (ASTRO) have released their 2022 clinical practice guideline for the management of clinically localized prostate cancer. Read More
ViewRay highlights presentation at ESTRO 2022
May 10, 2022 -- Image-guided radiation therapy ViewRay is highlighting research presented at this week's annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Copenhagen involving its MRIdian stereotactic MRI-guided radiation therapy technology. Read More
RaySearch, GE partner on radiation therapy planning
May 9, 2022 -- Radiation therapy software developer RaySearch Laboratories and GE Healthcare have partnered to develop a new radiation therapy simulation and treatment planning workflow that combines each company's technologies. Read More
Novartis suspends shipments of Lu-177 ligand therapy agents
May 6, 2022 -- Novartis has temporarily suspended supply of its two therapeutic radiopharmaceuticals based on lutetium-177 (Lu-177) ligands due to "quality issues identified in its manufacturing processes," the company said in a May 5 statement. Read More
RefleXion's outcome registry enrolls 1st cancer patient
May 5, 2022 -- Radiation therapy equipment developer RefleXion Medical has enrolled the first patient in its PREMIER registry, a clinical outcomes registry for patients with all stages of cancer treated with its RefleXion X1 system. Read More
Sun Nuclear releases 3D water scanner system
May 4, 2022 -- Radiation oncology quality-assurance (QA) technology developer Sun Nuclear released its SunScan 3D, a 3D cylindrical water scanner system for QA of linear accelerators. Read More
IBA acquires Modus Medical Devices
May 3, 2022 -- Proton therapy developer Ion Beam Applications (IBA) has purchased Canadian dosimetry phantom provider Modus Medical Devices. Read More
CIVCO plans new RT platform launch at ESTRO
May 3, 2022 -- Radiation therapy (RT) products provider CIVCO Radiotherapy will be introducing its TotalRT platform at the European Society for Radiotherapy and Oncology (ESTRO) meeting in Denmark this week. Read More
Special Feature
Representation in radiation oncology remains challenging
Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more
VENDOR CONNECT